0000000000193201

AUTHOR

Vitale A

showing 3 related works from this author

“Salvaguardia della Biodiversità: Polimorfismi del locus microsatellitare linked al gene della Rojal Gel Protein in Apis mellifera"

2005

researchProduct

Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre s…

2015

Background & Aims The role of hepatic resection for hepatocellular carcinoma (HCC) in different Barcelona Clinic Liver Cancer (BCLC) stages is controversial. We aimed at measuring the survival benefit of resection vs. non-surgical-therapies in each BCLC stage. Methods Using the ITA.LI.CA database, we identified 2090 BCLC A, B, and C HCC patients observed between 2000 and 2012: 550 underwent resection, 1046 loco-regional therapy (LRT), and 494 best supportive care (BSC). A multivariate log-logistic model was chosen to predict median survival (MS) after resection vs. MS after LRT or BSC. The results were expressed as net survival benefit of resection: (MS resection - MS LRT)/MS BSC. Resul…

Malemedicine.medical_specialtyCirrhosisCarcinoma HepatocellularLoco-regional therapieHepatocellular carcinomaSettore MED/12 - GASTROENTEROLOGIAHepatitis C virusKaplan-Meier Estimatemedicine.disease_causeGastroenterologyCohort StudiesLiver diseaseInterquartile rangeInternal medicinemedicineHumansBest supportive care; Cirrhosis; Hepatocellular carcinoma; Liver resection; Loco-regional therapies; Survival benefit; Aged; Carcinoma Hepatocellular; Cohort Studies; Female; Humans; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prognosis; Treatment Outcome; Medicine (all); HepatologyBEST SUPPORTING CAREAgedNeoplasm StagingCirrhosiHepatologyPerformance statusLiver resectionbusiness.industryMedicine (all)CIRRHOISISCarcinomaLiver NeoplasmsHepatocellularMiddle Agedmedicine.diseasePrognosisBCLC StageTreatment OutcomeCirrhosisItalySurvival benefitHepatocellular carcinomaMultivariate AnalysisFemaleLoco-regional therapiesLiver cancerbusinessBest supportive careJournal of hepatology
researchProduct

Prove preliminari di lotta biologica con Beauveria bassiana e Metarhizium anisopliae nei confronti del Punteruolo rosso

2009

Nell’intento di individuare limitatori biologici naturali di R. ferrugineus è stata valutata la potenziale attività antagonistica di due microrganismi fungini, appartenenti a specie dalle comprovate attitudini entomopatogene nei confronti di differenti stadi asintomatici dell’insetto (larve ed adulti). Più nel dettaglio, è stata saggiata l’efficacia di un ceppo di Beauveria bassiana, isolato da una larva con evidente efflorescenza fungina rinvenuta nel comune di Palermo e di un formulato commerciale a base di Metarhizium anisopliae e di B. bassiana. I saggi di inoculazione artificiale “in vitro” con queste note specie entomopatogene hanno indotto, in alcuni casi, la morte del 90% circa degl…

R. ferrugineus biocontrollo funghi entomopatogeni
researchProduct